Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1937
TNBC
Basal A
ICRF-193
TOP2
TOP
11849.157
uM
inf
inf
0.7560 0.7560 0.0000 0.1057
0.3086
1.4559
HCC1937
TNBC
Basal A
IKK16
IKK
NFKB
7453.093
uM
2.52090
3.43340
-0.9072 -0.8973 3.3269 0.3937
0.9976
1.5872
HCC1937
TNBC
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
7453.091
uM
21.68510
32.09540
-0.9340 -0.9418 2.7010 0.4583
0.9972
1.5914
HCC1937
TNBC
Basal A
Ispinesib
KSP
Kinesin
7452.067
uM
0.36718
2.15560
-0.9148 -1.0000 0.6207 0.4863
0.9435
1.7112
HCC1937
TNBC
Basal A
Ispinesib
KSP
Kinesin
7453.067
uM
0.49351
2.30660
-0.9441 -1.0000 0.7125 0.4479
0.9554
1.5080
HCC1937
TNBC
Basal A
Ixabepilone
TUBB
TUBB
7453.095
uM
0.09315
3.02390
-0.9133 -1.0000 0.3157 0.5409
0.7409
1.6395
HCC1937
TNBC
Basal A
Ixabepilone
TUBB
TUBB
7452.095
uM
0.53562
0.75487
-0.8571 -0.8566 2.9091 0.5528
0.9986
1.7316
HCC1937
TNBC
Basal A
JNK-IN-5A
JNK
JNK
11849.144
uM
inf
inf
0.6314 0.6314 0.0000 0.0592
0.5017
1.4131
HCC1937
TNBC
Basal A
L-779450
BRAF
MAPK
11849.161
uM
30.43390
37.91230
-0.5996 -1.0000 5.0000 0.0531
0.9916
1.2764
HCC1937
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
7453.098
uM
inf
inf
0.9252 0.9252 0.0000 0.0007
0.1372
1.4660
HCC1937
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
7452.098
uM
inf
9.96550
0.8503 0.7591 0.9473 0.0022
0.7737
1.6799
HCC1937
TNBC
Basal A
LBH589
HDAC
HDAC
11849.154
uM
0.18567
0.35457
-0.7180 -0.6832 1.3315 0.5922
0.9911
1.1927
HCC1937
TNBC
Basal A
Lestaurtinib
FLT3/JAK2/TrkA
RTK
11849.154
uM
0.65930
2.40320
-0.8887 -1.0000 0.8494 0.4267
0.9939
1.1927
HCC1937
TNBC
Basal A
Mebendazole
13115.174
uM
3.84060
1.74080
0.2960 0.4159 2.2527 0.1651
0.9403
0.8122
HCC1937
TNBC
Basal A
Methotrexate
DHFR
Metabolism
7452.084
uM
inf
inf
0.9680 0.9680 0.0000 -0.0014
0.1350
1.6800
HCC1937
TNBC
Basal A
Methotrexate
DHFR
Metabolism
7453.084
uM
inf
7.75030
0.9502 0.9560 4.9953 0.0060
0.5997
1.5592
HCC1937
TNBC
Basal A
Methylglyoxal
13115.184
uM
104.30230
312.93630
-0.9999 -1.0000 0.9999 0.8492
0.9661
0.7929
HCC1937
TNBC
Basal A
Methylglyoxal
13177.184
uM
504.29230
687.61710
-1.0000 -1.0000 3.5430 0.6770
0.9873
0.3394
HCC1937
TNBC
Basal A
MG-132
Proteasome
Proteasome
11849.145
uM
0.13365
0.16967
-0.8677 -0.8553 4.1787 0.8372
0.9991
1.5253
HCC1937
TNBC
Basal A
MG-132
Proteasome
Proteasome
11849.145
uM
0.13365
0.16967
-0.8677 -0.8553 4.1787 0.8372
0.9991
1.5253
HCC1937
TNBC
Basal A
Pevonedistat
NAE1
NAE1
11849.135
uM
6.13190
3.37530
0.3368 0.0975 0.3635 0.2657
0.9023
1.4337
HCC1937
TNBC
Basal A
Nelfinavir
13115.174
uM
6.86140
8.82710
-0.9981 -1.0000 4.3611 0.1920
0.9948
0.8122
HCC1937
TNBC
Basal A
Nilotinib
ABL
nRTK
11849.145
uM
inf
inf
1.0500 1.0500 0.0000 0.0324
0.0000
1.5253
HCC1937
TNBC
Basal A
NSC 663284
CDC25
CDC
11849.159
uM
0.99033
1.87210
-0.9671 -0.9997 1.7249 0.7658
0.9825
1.2484
HCC1937
TNBC
Basal A
NU6102
CDK1/2
CDK
11849.147
uM
46.87540
58.30410
-0.3167 -0.9885 5.0000 0.0811
0.9931
1.3461